Inhibition of proprotein convertase subtilisin-like kexin type 9 (PCSK9) potentiates anti-angiogenic therapy in colorectal cancer liver metastases
Miran Rada, Andrew R. Reynolds, Anthoula Lazaris, Nabil Georges Seidah, Peter P. Metrakos
This study shows that PCSK9 inhibition enhances anti-angiogenic therapy effectiveness in colorectal cancer liver metastases with vessel co-option.
bioRxiv · May 29, 2023 · PreprintMolecular Biology